Filing Flows › Kestra Medical Technologies (KMTS) › Q4 FY26
Kestra Medical Technologies (KMTS) Q4 FY26 earnings results (fourth quarter fiscal 2026)
10-K filed Jul 14, 2026
Kestra Medical Technologies (KMTS) reported revenue of $28.6M for the fourth quarter fiscal 2026 (Q4 FY26), +66% from a year earlier and +17% from the quarter before. Operating margin was -137.4%, net loss $38.8M (135.6% of revenue).
Kestra Medical Technologies, Q4 FY26: revenue $28.6M (+66% year over year), operating margin -137.4%, net loss $38.8M, operating cash flow −$18.7M. The chart follows the revenue to costs, profit and cash.
| Q4 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $28.6M | +17% | +66% |
| Operating profit | −$39.3M | — | — |
| Net earnings | −$38.8M | — | — |
| Operating cash flow | −$18.7M | — | — |
What changed
Revenue was $28.6M in Q4 FY26, up 66% year over year and up 17% from the previous quarter.
Gross margin was 54.8%, up 10.5 points from Q4 FY25. Operating costs exceeded revenue by $39.3M, an operating margin of -137.4%. Operating expenses fell 1% while revenue rose 66%. The quarter ended with a net loss of $38.8M, wider than the previous quarter's $34.2M loss.
Operating cash flow was −$18.7M. Non-cash charges added back $2.3M of depreciation and $10.3M of share-based compensation. Working capital and other items added $7.5M. Capital expenditures of $9.7M exceeded it, leaving free cash flow of −$28.4M.
Questions
What was Kestra Medical Technologies' revenue in the fourth quarter fiscal 2026?
Kestra Medical Technologies (KMTS) reported revenue of $28.6M for the fourth quarter fiscal 2026 (Q4 FY26), +66% from a year earlier and +17% from the quarter before.
Was Kestra Medical Technologies profitable in the fourth quarter fiscal 2026?
Operating loss was $39.3M (-137.4% of revenue) and net loss $38.8M.